Skip to content

GENATRONICS: value indication

Line	Code	2025	2026	Change	%
Total assets	20/58	€29,783	€21,621	-€8,162	-27.4%
Fixed assets	21/28	€3,995	€2,092	-€1,903	-47.6%
Tangible fixed assets	22/27	€3,995	€2,092	-€1,903	-47.6%
Plant, machinery and equipment	23	€2,961	€1,471	-€1,490	-50.3%
Furniture and vehicles	24	€1,033	€621	-€413	-40.0%
Current assets	29/58	€25,788	€19,529	-€6,259	-24.3%
Stocks and contracts in progress	3	€12,586	€7,840	-€4,746	-37.7%
Stocks	30/36	€12,586	€7,840	-€4,746	-37.7%
Amounts receivable within one year	40/41	€11,831	€9,366	-€2,465	-20.8%
Trade receivables	40	€4,776	€184	-€4,592	-96.1%
Other amounts receivable	41	€7,055	€9,182	+€2,128	+30.2%
Cash at bank and in hand	54/58	€400	€1,301	+€901	+226%
Deferred charges and accrued income	490/1	€972	€1,023	+€51	+5.2%
Total equity and liabilities	10/49	€29,783	€21,621	-€8,162	-27.4%
Equity	10/15	€24,356	€21,341	-€3,015	-12.4%
Contributions	10/11	€9,300	€9,300	=	0.0%
Capital	10	€9,300	-	-€9,300
Issued capital	100	€18,600	-	-€18,600
Uncalled capital	101	€9,300	-	-€9,300
Contributions outside capital	11	-	€9,300	+€9,300
Other	1109/19	-	€9,300	+€9,300
Reserves	13	€9,324	€12,041	+€2,718	+29.1%
Non-distributable reserves	130/1	€1,860	€1,860	=	0.0%
Legal reserve	130	€1,860	€1,860	=	0.0%
Distributable reserves	133	€7,464	€10,181	+€2,718	+36.4%
Profit (loss) carried forward	14	€5,732	-	-€5,732
Amounts payable	17/49	€5,427	€280	-€5,147	-94.8%
Amounts payable after more than one year	17	€2,620	-	-€2,620
Financial debts	170/4	€2,620	-	-€2,620
Amounts payable within one year	42/48	€2,750	€254	-€2,496	-90.8%
Trade debts	44	€2,477	€252	-€2,226	-89.8%
Suppliers	440/4	€2,477	€252	-€2,226	-89.8%
Taxes, remuneration and social security	45	€273	€2	-€271	-99.3%
Taxes	450/3	€273	€2	-€271	-99.3%
Accrued charges and deferred income	492/3	€57	€26	-€31	-53.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets	630	€1,055	€1,263	+€208	+19.7%
Other operating charges	640/8	€1,753	€456	-€1,296	-74.0%
Non-recurring operating charges	66A	-	€640	+€640
Gross operating margin	9900	€11,560	-€878	-€12,437
Operating profit (loss)	9901	€8,752	-€3,237	-€11,989
Financial income	75/76B	€14	€462	+€448	+3,122%
Recurring financial income	75	€14	€462	+€448	+3,122%
Financial charges	65/66B	€391	€74	-€317	-81.1%
Recurring financial charges	65	€391	€74	-€317	-81.1%
Profit (loss) for the period before taxes	9903	€8,375	-€2,849	-€11,224
Income taxes	67/77	€912	€166	-€746	-81.8%
Profit (loss) for the period	9904	€7,464	-€3,015	-€10,478
Profit (loss) for the period to be appropriated	9905	€7,464	-€3,015	-€10,478

GENATRONICS: value indication

GENATRONICS: value indication

Position among the sector peers

What moved between 2025 and 2026

Largest movements

Change in the result, 2025 to 2026

Derived cash bridge

Value

Indicative value of the equity

Adjusted equity

Capitalised earnings

Your EBITDA multiple

Limits of the indication

Next steps